Apolar trisubstituted derivatives of harmine show high antiproliferative activity on diverse cancer cell lines. However, these molecules present a poor solubility making these compounds poorly bioavailable. Here, new compounds were synthesized in order to improve solubility while retaining antiproliferative activity. First, polar substituents have shown a higher solubility but a loss of antiproliferative activity. Second, a Comparative Molecular Field Analysis (CoMFA) model was developed, guiding the design and synthesis of eight new compounds. Characterization has underlined the in vitro antiproliferative character of these compounds on five cancerous cell lines, combining with a high solubility at physiological pH, making these molecules druggable. Moreover, targeting glioma treatment, human intestinal absorption and blood brain penetration have been calculated, showing high absorption and penetration properties.
Introduction
Harmine (1) is a natural b-carboline compound, which is a major alkaloid from Peganum harmala and Banisteriopsis caapi, presenting antiproliferative activity. This later property is attributed to several mechanisms of action such as antiangiogenesis activity on endothelial cells [1, 2] , apoptosis induction [3] or reverse drug resistance by inhibition of the Breast Cancer Resistance Protein-mediated drug efflux protein [4] . Based on these antiproliferative properties, our group previously synthesized about fifty harmine derivatives 2aeas substituted on the 2, 7 or/and 9 position(s) (structure on Supporting information) [5] . Their in vitro growth inhibitory activity (determination of the IC 50 concentration) was evaluated on three glioma (U373, T98G, Hs683) and two oesophageal cancer cell lines (OE21, OE33) from human origin. This work highlighted that the 2,7,9-trisubstituted compounds were the most potent derivatives with some of them reaching a submicromolar antiproliferative activity ( Fig. 1 ) [5] . Moreover, the growth inhibitory potency of the best compounds was in the same range, both on cells resistant or not to apoptotic stimuli [6] .
Quantitative videomicroscopy have shown a cytostatic behaviour on U373 glioma cell line [5] .
To elucidate the mechanism of action of the 2aec antiproliferative molecules, anti-cancer profiles on the 60 cancer cell line panel of the National Cancer Institute (Bethesda, USA) were evaluated and compared to those of the 763,000 compounds of the NCI database [7] . The highest correlation was found with protein synthesis inhibitors, an hypothesis that was further confirmed by western blot on the eukaryotic initiation factor 2 (eiF2a) implicated in protein synthesis [5, 8] .
Despite a strong antiproliferative activity in vitro, these trisubstituted compounds possess a poor solubility at physiological pH, which is detrimental for their bioavailability and their development as drug [9] . In order to obtain novel druggable harmine-based antiproliferative molecules, and following the concept of early-ADME which leads to improve both biological and ADME properties, the goal of this work was to increase the solubility of the b-carboline derivatives preserving their antiproliferative activity on cancer cells [10] . On one hand, new b-carbolines were synthesized bearing polar substituents in order to a priori improve their solubility. On the other hand, a Comparative Molecular Field Analysis (CoMFA) model was generated to guide the synthesis of new molecules. The physicochemical properties (solubility, lipophilicity) and the antiproliferative activity (MTT colorimetric test, quantitative videomicroscopy) have been investigated for each newly synthesized compound. Finally, to mimic oral absorption and brain uptake which is required for glioma treatment, human intestinal absorption and blood brain barrier penetration have been calculated.
Results

Chemistry
Targeted 2,7,9-trisubstituted compounds (4feh and 5cej) and intermediates (Table 1 ) discussed in this work were synthesized following the strategy depicted on Scheme 1 [5] . Starting from harmol, the 7-desmethyl harmine, two routes have been adopted to obtain 7,9-disubstituted derivatives. First pathway, used when R7 is different from R9, is a two-step procedure involving O 7 -alkylation of harmol by an alkyl-, a branched alkyl-or benzyl bromide in presence of caesium carbonate in DMF (2j, 3) (a). Then, the O 7 -substituted compound reacts with iodopropane and sodium hydride under argon in DMF to give the 7,9-disubstituted compounds 2w and 5a (b). A different strategy was used to obtain 4a. In this case, 3 reacts with acrylonitrile and Triton B to add the N 9 -propionitrile substituent (c) [11] . In the second pathway, used when R7 is identical to R9, 4b and 5b were synthesized by a simultaneous O 7 -and N 9 -alkylation of harmol using the required alkylbromide and potassium hydroxide in DMF (d). 2,7,9-trisubstituted compounds 5cej were obtained by a N 2 -alkylation of the corresponding 7,9-disubstituted compound in presence of the required alkylbromide in THF (e). The nitrile derivative 4e, obtained by the pathway (e), was converted into the corresponding tetrazole (4f) by using sodium azide and ammonium chloride in DMF (f) [11] . Hydroxyl alkyl substituents, benzyl ethers 4c and 4d, obtained following (e) pathway, were reduced by Pd-catalysed hydrogenation using Pd/C affording 4g and 4h respectively (g) [12] . These last two reactions led to targeted trisubstituted compounds bearing charged (4f) or neutral (4geh) polar substituent(s) unlike targeted compounds 5cej which only bear apolar substituents. The structure and purity of each final synthesized compound were analysed by 1 H NMR, 13 C NMR, LC, MS and elemental microanalyses.
Physicochemical characterization
Experimental aqueous solubility at pH 7.4 and theoretical lipophilicity (Advanced Chemistry Development, Inc., ACD/Lab) [13] of compounds 4feh and 5cej were compared with the results obtained for the most active b-carboline of the first generation (2aec) as shown in Table 1 . Aryl and cycloalkyl substituents of 2aec are responsible for their high molecular weight (MW > 500 g/mol) and lipophilicity (logP>5) over Lipinski's rules [14] . Moreover, the poor solubility of 2aec is due to the presence of an aryl, an aryl halide or a cyclohexyl substituent. Addition of hydroxylated substituents (4geh) or small branched/linear alkyl moieties (5cej) strongly improves the solubility at physiological pH which become higher than 200 mg/ml and 160 mg/ml, respectively. Each newly synthesized compound (4feh and 5cej) offers, as expected, a lower molecular weight (MW < 500 g/mol) and a decreased lipophilicity (logP<5).
Biological characterization
a) Determination of the in vitro growth inhibitory activity Determination of in vitro growth inhibitory activity was performed on three glioma cell lines (U373, T98G, Hs683), one melanoma (SKMEL-28) and one lung cancer (A549) cell line using a MTT colorimetric assay [15] . Cells were cultured during three days in presence (test) or absence (control) of 4feh and 5cej compound at concentrations from 10 nM to 100 mM. For each b-carboline, the concentration required to reduce the global growth by 50% (the IC 50 concentration) was determined on each cell line (Table 2) . Compounds 4feh bearing polar substituents (tetrazole or hydroxyalkyl) are inactive (IC 50 > 100 mM), independently of the presence of a charge at physiological pH (4f) or not (4geh). On the contrary, molecules 5cej exhibit an IC 50 concentration in the micromolar to submicromolar range which makes these compounds more active than harmine (IC 50 ¼ 28 mM) [5] . It is interesting to highlight that: -For the same substituent on the N 2 -and N 9 -positions, the IC 50 is 20-times lower when the O 7 -propyl is replaced by an isopentyl moiety (5c vs 5h and 5d vs 5j). -Within the O 7 -isopentyl derivative series, activity is improved when R2 is also a branched alkyl (5he5j).
These observations underline the important effect of branched substituents of the harmine skeleton on antiproliferative effect. b) Cytotoxic and cytostatic effects of compounds on U373, Hs683 and SKMEL-28 cells
As 2aec display cytostatic activity on U373 glioma cell line at IC 50 concentration [5] , we examined the antiproliferative activity of the best inhibitors (5f, 5h, 5j) on the same U373 glioma cell line as well as on Hs683 glioma and SKMEL-28 melanoma cell lines using quantitative videomicroscopy (Fig. 2) (results on Hs683 and SKMEL-28 in Supporting information). Cells were seeded and cultured 72 h in the presence (test) or absence (control) of the bcarboline derivative, at a concentration corresponding to their IC 50 concentration determined by the MTT colorimetric test. A picture of the bottom flask is registered each 4 min during the 72 h of observation. The condensation of the 1080 images generated a 40s movie for each experiment operated in triplicate. Results on the three tested cell lines show a morphological cytostatic effect of the compounds 5f, 5h and 5j at their IC 50 concentration, which are 1, 1 and 0.5 mM respectively.
Computational chemistry
In order to generate a CoMFA model, 49 structures of b-carbolines (1, 2a-as and 4feg compounds) were aligned on a pharmacophore to have alignment principally based on substituents. This alignment was performed in two steps in order to produce the best alignment of b-carboline compounds. The first step aimed to generate a starting pharmacophore with 2a, 2ae and 2ap (see structures in Supporting information) as training set with merged features. Based on this first pharmacophore, information about the harmine tricycle and the positive charge were removed in order to generate a bias pharmacophore including only information about the substituents. In the second step, a second pharmacophore was generated based on the bias pharmacophore with 2ac, 2aq, 2ae and 2c as training set. The final alignment of all compounds, performed with LigandScout 3.03 [16] , is depicted on Fig. 3A . The CoMFA model was generated on Sybyl 8.1 software [17] on 80% of the molecules (training set). These molecules were chosen randomly by Discovery Studio 3.5 [18] . The remaining 20% molecules were used as a test set. CoMFA model was elaborated using pIC 50 activity on Hs683 cell line.
PLS statistics obtained during the development of the model are summarized in Table 3 . The cross-validated correlation coefficient (q 2 ) represents the prediction capacity of the model and the conventional correlation coefficient (r 2 ) represents the capacity to fit the data with the 3D-QSAR model. The high value of r 2 indicates a good fitting of the derived model [19] . Moreover, the low standard error of estimate (0.314) and the important value for Fisher test indicate that an important part of the data is explained by the model. Contributions of steric and electrostatic fields are similar with 46.1% and 53.9%, respectively. The experimental versus predicted pIC 50 data are depicted on Fig. 4 , showing a good prediction of data for training and test sets (data are summarized in Supporting information for 1, 2aeas and in Table 2 for 4feh). 
Human intestinal absorption and blood brain barrier penetration calculation
Calculations have been performed with Discovery Studio software, using two developed models based on descriptors such as 2D polar surface area and AlogP98 calculations [18, 20] . Models define four prediction levels for the intestinal absorption (from good to very poor) and blood brain barrier (from very high to low penetrants plus an undefined level) after oral administration. These different levels are defined by confidence ellipsoids at 95% and 99%. For human intestinal absorption, compounds depicted inside the ellipsoids are determined as well absorbed compounds (>90% absorbed) while compounds outside ellipsoids are predicted as poorly absorbed compounds (<30% absorbed). For blood brain barrier penetration, the definition is quite different: molecules outside the ellipsoids are undefined, while in the ellipsoids four regions are drawn corresponding to the four levels of BBB penetration. Fig. 5 shows that 2aec compounds are predicted as very poorly absorbed by human intestines (A) and are undefined with respect to their blood brain penetration (B), while compounds 5cej are characterized by a good intestinal absorption (A) and very high brain penetration (B), therefore making these compounds more druggable.
Discussion and conclusions
In order to improve the solubility of 2,7,9-trisubstituted harmine derivatives with antiproliferative activity and to expand the range of studied substituents, compounds bearing polar substituents (4feh) have been synthesized and their physicochemical properties (Table 1 ) and antiproliferative efficacy (Table 2) were evaluated.
Results indicate that polar substituents on b-carboline template increase solubility (>200 mg/ml) at physiological pH, as expected, but unfortunately, strongly reduce their antiproliferative activity with a mean IC 50 higher than 100 mM. Moreover, compared to the growth inhibitory activity of harmine (IC 50 ¼ 28 mM) [5] , the IC 50 value of 4feh show that polar substituents are not favourable for antiproliferative activity of trisubstituted b-carbolines.
As an alternative, a CoMFA model has been generated based on 1, 2a-as and 4feh biological activity in order to suggest molecules combining antiproliferative activity in the micromolar range and higher solubility than compounds 2aec. This model gives a good prediction of pIC 50 values compared to experimental pIC 50 values on Hs683 glioma cell line (Fig. 4) and highlights steric and electrostatic contributions essential for antiproliferative activity. In order to visualize CoMFA model, contour maps were generated around compound 2a (Fig. 3B ). Several conclusions can be drawn based on these maps; firstly, the nature of O 7 -substituent has little influence on the biological activity; secondly, N 9 -and N 2 -substituents must be sterically small; thirdly, the positive charge due to the presence of the third substituent is favourable to biological activity.
Based on these observations and in order to decrease the lipophilicity of initial molecules, diverse small substituents including propyl, isopentyl and benzyl were linked to the harmine ring (5cej). Combination of these substituents leads to 8 new molecules whose calculated lipophilicity fits with Lipinski's rules (logP<3.4) ( Table 1) . Moreover, their biological activity on Hs683 glioma cell predicted by the CoMFA model suggest that those molecule present an antiproliferative effect in the micromolar range ( Table 2 ). Among these 8 molecules, three of them, bearing an ethyl substituents on R2 position (5c, 5e, 5h) (not included in the training set) are predicted as less active than the others compounds. However, as these three molecules present a lower molecular weight and calculated lipophilicity compared to initial compounds, these molecules have been synthesized and included in our study.
Physicochemical characterization underlined a higher solubility of these compounds 5cej compared to 2aec. Because the reference molecules (2aec) and targeted molecules 5cej have the same bcarboline skeleton, we can relate the best solubility and lipophilicity to the decreased number of carbon atoms substituting the molecules, which make these compounds more "druggable" than 2aec. Biological characterization highlighted that these soluble compounds offer an antiproliferative activity in the micromolar to submicromolar range on five cancerous cell lines. 5f, 5h and 5j are the best antiproliferative compounds. Moreover, the experimental antiproliferative activity of compounds bearing an ethyl moiety (5c, 5e and 5h) present a submicromolar IC 50 on Hs683 glioma cells, despite a poor CoMFA prediction (Table 2 ). This conclusion highlights the underestimated inhibitory potential of the ethyl substituent (not part of training set) by the generated model.
As the first generation of harmine substituted compounds (2aec) has a cytostatic profile on U373 glioma cell line, quantitative videomicroscopy experiment was performed on the new molecules, highlighting a similar cytostatic behaviour of these compounds on three cancerous cell lines including two glioma cell lines.
With the aim to develop novel antiproliferative b-carboline which are orally bioavailable and focussing particularly on glioma treatment, human intestinal absorption and blood brain barrier penetration of newly synthesized compounds were calculated with Discovery Studio 3.5 software [18] . Results show better intestinal absorption and bloodebrain barrier penetration for 5cej compounds compared to 2aec. Fig. 5 shows that the different features of compounds 2aec and 5cej are due to their difference in lipophilicity rather than their 2D polar surface area, which is the same for these molecules characterized by the same skeleton bearing apolar substituents. Compounds 2aec, with aromatic substituents, are too lipophilic (logP>5) which is not propitious for a good oral bioavailability, as opposed to 5cej compounds substituted by small alkyl groups, which have a lower lipophilicity (logP<3.4) and are predicted to be very well absorbed.
In conclusion, in the continuation of our previous results
showing that trisubstituted b-carbolines 2aec present an antiproliferative activity but a low solubility at pH 7.4 and using an early-ADME concept, new molecules combining antiproliferative activity and an improved solubility at pH 7.4 have been synthesized. compounds with increased antiproliferative activity for 5f, 5h and 5j compounds. Our results are in agreement with those recently presented by Cao and co-workers who have also presented good antiproliferative activity for trisubstituted harmine derivatives [21] . Quantitative videomicroscopy underlines a cytostatic effect of these three molecules on U373, Hs683 and SKMEL-28 cancer cell lines. Moreover, human intestinal absorption and blood brain barrier penetration has been calculated for 5cej, compared with initial compounds (2aec) and suggests better druggability of the newly synthesized molecules mainly due to their decreased lipophilicity. . Elemental analyses were determined on a FlashEA 1112 series organic elemental analyzer. Thin-layer chromatography was realized on silica gel plates (silica gel GF254, VWR) visualized at 254 nm. Column chromatography was realized in a BiotageSP1 25 þ M column equipped with UV spectrophotometer with a detector (wavelengths of 254 nm and 320 nm). Solvents from Biosolve were used without further purification. Microwave irradiation was realized on a Biotage initiator 2.0 apparatus in 20 ml sealed tube. All new compounds were determined to be >95% pure by LC-MS. General procedure for simultaneous O-7 and N-9 alkylation (A): The synthesis was performed as described elsewhere [5] . Briefly, harmol (1.50 g, 5 mmol) was dissolved in DMF (30 ml). An amount of 5 equiv of potassium hydroxide was added and the mixture was stirred for 30 min under argon. Then, 2 equiv of alkyl bromide was added. The mixture was stirred at room temperature overnight under argon. The reaction was followed by TLC (85:15 dichloromethane: ethanol). At the end of the reaction, the mixture was extracted using dichloromethane. The organic layer was washed with water and brine and dried with MgSO 4 , which was collected by filtration. The organic layer was evaporated under vacuum and the crude product was purified via column chromatography with dichloromethane/ethanol (100:0 to 70:30) used as the eluent.
General procedure O-7 alkylation (B): The synthesis was performed as described elsewhere [22] . Briefly, harmol (1.5 g, 5 mmol) was dissolved in DMF (30 ml). An amount of 1.5 equiv of alkyl bromide and 3 equiv of caesium carbonate were added. The mixture was stirred during 24 h at room temperature, under argon. The reaction was followed by TLC (85:15 dichloromethane: ethanol). At the end of the reaction, the mixture was extracted using dichloromethane. The organic layer was washed with water and brine and dried with MgSO 4 , which was collected by filtration. The organic layer was evaporated under vacuum and the crude product was purified via column chromatography with dichloromethane/ethanol (100:0 to 80:20) used as the eluent.
General procedure for N-9 alkylation (C): The 1-methyl-O7-substituted-7-hydroxy-b-carboline (1.25 g) was dissolved in DMF. An amount of 1.5 equiv of iodopropane and 5 equiv of sodium hydride were added. The mixture was stirred overnight under Argon. The reaction was followed by TLC (85:15 dichloromethane: ethanol). At the end of the reaction, the mixture was extracted using dichloromethane. The organic layer was washed with water and brine and dried with MgSO 4 , which was collected by filtration. The organic layer was evaporated under vacuum and the crude product was purified via column chromatography with dichloromethane/ethanol (100:0 to 87:13) used as the eluent.
General procedure for microwave assisted synthesis of N-2 alkylation (D): The synthesis was performed as described elsewhere [5] . Briefly, 1-methyl-O7-substituted-N9-substituted-7-hydroxy-b-carboline (0.300 g) was dissolved in THF (10 ml). An amount of 10 equiv of alkyl bromide was added. The mixture was placed on a microwave reactor at 140 C during 4 h. The reaction was followed by TLC (85:15 dichloromethane: ethanol). At the end of the reaction, precipitate was filtrate without any purification or the mixture was extracted using dichloromethane. The organic layer was washed with water and brine and dried with MgSO 4 , which was collected by filtration. The organic layer was evaporated under vacuum and the crude product was purified via column chromatography with dichloromethane: ethanol (100:0 to 70:30) used as the eluent.
Synthesis. Synthesis of compounds 2ae2as has been previously reported [5, 22] .
7-(Isopentyloxy)-1-methyl-b-carboline, 3
The title compound was synthesized according to the general procedure B from 1-methyl-7-hydroxy-b-carboline (harmol) (1.98 g, 7.4 mmol) in the presence of caesium carbonate (7.21 g, 22.2 mmol), 1-bromo-3-methylbutane (1.4 ml, 11.1 mmol) in 50 ml of DMF. A yellow solid was obtained. Yield 65%, Mp 235e237 C, MS: [MþH] þ 269.0, Rf ¼ 0. 
7-(Isopentyloxy)-1-methyl-9-propionitrile-b-carboline, 4a
The title compound was synthesized according a method describe elsewhere [11] . 3 (1.289 g, 4.5 mmol) and acrylonitrile (3.0 ml, 45 mmol) were stirred. Addition dropwise of TritonB (0.28 ml, 1.54 mmol) leads to a red solution followed by TLC (85:15 dichloromethane: ethanol). After completion of the reaction, the mixture was extracted with dichloromethane (100 ml) and organic layer was washed with water and brine. The organic layer was evaporated under vacuum and the crude product was used without any purification. An orange solid was obtained. 
7-(2-Benzyloxyethoxy)-9-(2-benzyloxyethyl)-1-methyl-bcarboline, 4b
The title compound was synthesized according to the general procedure A from harmol (1.98 g, 7.4 mmol) in the presence of benzyl-2-bromoethylether (2.4 ml, 14.8 mmol) and potassium hydroxide (2.10 g, 37 mmol) in 40 ml of DMF. A white solid was obtained after crystallization in EtOH. Yield 52%, Mp 82e83 C, MS: [MþH] þ 467.0, Rf ¼ 0. 
The title compound was synthesized according to the general procedure D from 4b (0.307 g, 0.6 mmol) in the presence of 1-bromo-3-methylpropane (0.78 ml, 6.4 mmol) in 15 
The title compound was synthesized according to the general procedure D from 4b (0.394 g, 0.84 mmol) in the presence of benzyl-2-bromoethylether (2.0 ml, 12.7 mmol) in 15 
The title compound was synthesized according a procedure describe elsewhere [11] . 4e (0.349 g, 0.74 mmol) in the presence of sodium azide (0.217 g, 3.3 mmol) and ammonium chloride (0.155 g, 2.9 mmol) in 4 ml of DMF was refluxed 12 h. The reaction was followed by TLC (85:15 dichloromethane: ethanol). After completion of the reaction, the mixture was extracted with dichloromethane and organic layer was washed with water and brine and dried with MgSO 4 . The organic layer was evaporated under vacuum and the crude product was purified via column chromatography with dichloromethane/ethanol (100:0 to 50:50) used as the eluent. 
The title compound was synthesized from 4c (0.160 g, 0.26 mmol) in the presence of Pd/C 10% (41.6 mg, 0.04 mmol) and H 2 (1 bar) in 20 ml of ethanol. The reaction was followed by TLC (85:15 dichloromethane: ethanol). After completion of the reaction, the mixture was filtered under celite and was evaporated under vacuum. The crude extract was crystallized with hot ethanol to give the title compound. A yellow solid was obtained after crystallization in EtOH. Yield 96%, Mp 232e234 C, HRMS Calcd for C 21 
The title compound was synthesized according to the general procedure C from 3 (1.265 g, 4.7 mmol) in the presence of iodopropane (1.198 4.1.11. 1-Methyl-7-Propoxy-9-propyl-b-carboline, 5b
The title compound was synthesized according to the general procedure A from harmol (1.50 g, 4.78 mmol) in the presence of bromopropane (0.8 ml, 9.55 mmol) and potassium hydroxide in 30 ml of DMF. A yellow solid was obtained. 2aeas and 4feh compounds) . The IC 50 (M) obtained on this cell line was transformed into pIC 50 (-logIC 50 ). Data set was divided randomly into a training set (80%: 39 compounds) and a test set (20%: 10 compounds) using Discovery Studio 3.5.
Alignment
Alignment was generated using LigandScout 3.03 software. This alignment was elaborated in two steps: first step was to generate a pharmacophore using 2a, 2ad and 2ap as training set, using merged features. Based on this pharmacophore, features from b-carboline tricycle and positive charge were removed in order to give a bias pharmacophore. Based on this bias pharmacophore, the second step was to generate a second pharmacophore using 2c, 2ac, 2an and 2aq as training set. This combination of steps induces the best alignment for the whole b-carboline discussed in this work.
CoMFA analyse
CoMFA model was generated using Sybyl 8.1 software (TRIPOS Associates Inc.). Charges were calculated by the MMFF94s method in the software. CoMFA calculations were performed using default values. Steric and electrostatics fields were calculated at each grid points using an sp3 carbon atom probe with 1.52 Å Van der Waals radius for steric field and a þ1.0 charge for electrostatic filed, with an energy cut-off value of 30 kcal/mol.
Partial Least Square (PLS) analyses
In order to evaluate statistically the 3D-QSAR model, PLS regression was used. A Leave-One-Out method was performed in order to obtain a crossvalidated coefficient correlation and the optimal number of components used in the final analysis. A column filtering of 2.0 kcal/mol was set. The non-crossvalidation analysis was performed and leads to a conventional correlation coefficient, the standard error of estimate and the Fisher-test value which determine the goodness-of-fit.
In vitro growth inhibitory activity
MTT colorimetric assay was performed on different cancerous cells (U373, T98G, Hs683, SKMEL-28, A549, MCF-7) using a protocol described previously [15] . The histological types and origins of the six cancer cell lines that were used for the MTT colorimetric assay are as follows. The cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA), the European Collection of Cell Culture (ECACC, Salisbury, UK) and the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany). The analysed cell lines include the U373 (ECACC code 08061901), Hs683 (ATCC code HTB-138) and T98G (ATCC code CRL-1690) gliomas; the SKMEL-28 melanoma (ATCC code HTB-72); the MCF-7 breast (DSMZ code ACC115) and the A549 non-small-cell lung (NSCLC; DSMZ code ACC107) carcinoma models. All cell lines are from human origin.
Quantitative videomicroscopy
Quantitative videomicroscopy was performed on U373, Hs683 and SKMEL28 cancer cells at the IC 50 determined by the MTT colorimetric test for each compound of interest, using the same protocol as previously [5] .
Solubility
Solubility experiment was performed using a protocol described previously [23] .
ADME prediction
Human intestinal absorption and blood brain barrier penetration after oral administration were calculated using Discovery Studio 3.5 software [18] . For human intestinal absorption, a model was developed using 182 compounds in the training set with descriptors such as AlogP98 and 2D polar surface area [20] . Well absorbed compounds (>90% absorbed) are situated in an ellipse of 95% and 99% of confidence. Blood brain barrier model was generated using 102 compounds in a training set and 86 compounds in a test set. This model was after validated twice using 881 compounds known as CNS compounds from the CMC database and using 124 compounds with known logBB value [18] . Prediction of BBB penetration is divided into 4 levels (very high to low) included onto 95% and 99% confidence ellipse and an undefined level excluded from the confidence ellipses.
